3-(2-aminoethyl)-5-(2-ethoxybenzylidene)thiazolidine-2,4-dione

ID: ALA569545

PubChem CID: 43328130

Max Phase: Preclinical

Molecular Formula: C14H16N2O3S

Molecular Weight: 292.36

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCOc1ccccc1/C=C1\SC(=O)N(CCN)C1=O

Standard InChI:  InChI=1S/C14H16N2O3S/c1-2-19-11-6-4-3-5-10(11)9-12-13(17)16(8-7-15)14(18)20-12/h3-6,9H,2,7-8,15H2,1H3/b12-9-

Standard InChI Key:  AVQYNOLICLPPNI-XFXZXTDPSA-N

Molfile:  

     RDKit          2D

 20 21  0  0  0  0  0  0  0  0999 V2000
   -4.3095   -2.5039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3106   -3.3312    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5958   -3.7441    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8795   -3.3307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8823   -2.5003    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5976   -2.0912    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1694   -2.0851    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4528   -2.4947    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2065   -3.2814    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3816   -3.2894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1184   -2.5068    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7817   -2.0160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0968   -3.9614    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7742   -1.1911    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5978   -2.0973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3104   -2.5129    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0266   -2.1035    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1643   -3.7421    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1631   -4.5671    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4480   -4.9784    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
  5  6  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12  8  1  0
  6  1  1  0
 10 13  2  0
  1  2  2  0
 12 14  2  0
  5  7  1  0
 11 15  1  0
  3  4  2  0
 15 16  1  0
  7  8  2  0
 16 17  1  0
  8  9  1  0
  4 18  1  0
 18 19  1  0
  4  5  1  0
 19 20  1  0
M  END

Associated Targets(Human)

RPS6KA1 Tchem Ribosomal protein S6 kinase alpha 1 (2796 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK3 Tchem Mitogen-activated protein kinase; ERK1/ERK2 (651 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ELK1 Tbio ETS domain protein Elk-1 (6 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK13 Tchem MAP kinase p38 (1586 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK1 Tchem MAP kinase ERK2 (25055 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U-937 (7138 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 292.36Molecular Weight (Monoisotopic): 292.0882AlogP: 2.08#Rotatable Bonds: 5
Polar Surface Area: 72.63Molecular Species: BASEHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.14CX LogP: 1.48CX LogD: -0.25
Aromatic Rings: 1Heavy Atoms: 20QED Weighted: 0.84Np Likeness Score: -1.79

References

1. Li Q, Al-Ayoubi A, Guo T, Zheng H, Sarkar A, Nguyen T, Eblen ST, Grant S, Kellogg GE, Zhang S..  (2009)  Structure-activity relationship (SAR) studies of 3-(2-amino-ethyl)-5-(4-ethoxy-benzylidene)-thiazolidine-2,4-dione: development of potential substrate-specific ERK1/2 inhibitors.,  19  (21): [PMID:19796943] [10.1016/j.bmcl.2009.09.057]

Source